Medicare reviewers treat a wound's infection status as the fact that decides whether treatment, debridement, or a skin substitute application was medically necessary in the first place. A chart that never documents whether a wound was infected, orders a culture without a clinical reason to suspect infection, or skips the biopsy a suspected bone infection calls for, hands a Recovery Audit Contractor, a Unified Program Integrity Contractor, or a Medicare Administrative Contractor the exact gap it is built to find. The exposure runs past a denied claim: federal prosecutors have charged providers specifically over allografts applied to infected wounds.
Infection Signs and the Medical Necessity Record
Medicare's Local Coverage Determination for wound and ulcer care, L38902, requires the record to state the presence, extent, or absence of obvious signs of infection at every visit, documented through the wound's exudate, meaning its amount, turbidity, color, and odor, and through any cellulitis in the surrounding tissue. That line in the chart lets a reviewer connect a billed treatment, debridement code, or skin substitute application to a documented clinical reason rather than a routine visit. Medicare Wound Care Documentation: The Chart That Survives Audit covers the measurement, photographic, and signature elements of that chart; infection status is the piece those elements do not capture on their own.
Wound Cultures and the Decision to Treat
A wound culture earns its place in the record when a clinical sign points to infection, not as a standing order run on every chronic wound regardless of how it looks. The same LCD ties continued coverage to documented healing, and calls for a physician reassessment, which may include evaluating underlying infection, when a wound has not progressed as expected after 30 days. A culture ordered at that point, with the clinical finding that triggered it written into the note, is what shows a reviewer that the test, and whatever followed it, a change in debridement frequency or a course of antibiotics, was medically necessary rather than discretionary.
Tissue Biopsy and Suspected Osteomyelitis
Medicare's debridement coverage does not condition payment on a bone biopsy before billing a procedure that reaches bone. The record has to show debridement reached bone, documented through findings such as necrosis of bone; the LCD encourages a pathology report substantiating the depth for deep-tissue or bone procedures. Clinically, a bone biopsy with culture and histopathology remains the standard for confirming osteomyelitis, because a surface swab does not reliably identify the organism causing a deeper bone infection. The same biopsy evidence reaches skin substitute decisions: a graft placed over a wound whose infection or biofilm was never resolved is the fact pattern federal fraud cases have targeted by name. For a venous ulcer, the LCD cites a nursing society's guideline recommending a tissue biopsy or swab to determine bacterial bioburden when biofilm is suspected.
How Reviewers Read the Infection Record
A reviewer reconstructing one of these claims checks whether the infection narrative holds together across visits, whether an ordered culture or pathology report appears in the chart with its result, and whether the stated diagnosis matches the code billed. A lab result never signed into the record, or one that cannot be matched to its author against the practice's signature log, reads to a reviewer as if the test were never documented at all. Middle District of Florida prosecutors charged a nurse practitioner and two nurses in the 2026 National Health Care Fraud Takedown with billing Medicare for allografts applied to infected wounds, among other allegations. The same gap, between an infection that was present and a record that did not say so, is what a RAC or UPIC review is built to find, well before a case reaches a prosecutor.
A reviewer who cannot find the infection in the chart treats the claim as if the infection was never there.
Why Early Legal Counsel Is Critical
It is critical that wound care providers promptly retain experienced healthcare defense counsel upon receiving a records request, audit notice, or program-integrity inquiry tied to infection, culture, or biopsy documentation. Early legal intervention can protect the provider's rights, support an accurate response, avoid inadvertent admissions, preserve relevant defenses, and allow counsel to communicate with the reviewer on the provider's behalf. Delaying representation can affect the outcome of the review and expose the provider to recoupment or referral risk an early response could have prevented.
How Health Law Alliance Can Help
Health Law Alliance's attorneys have overseen 2,000+ audits and handled 5,000+ matters, with 25+ years of experience. Alison Goldman defends wound care providers whose infection, culture, and biopsy documentation is under Medicare review, from a records request through an extrapolated finding. Contact us for a free, confidential consultation on wound care audit defense.





